Published in Eur J Vasc Endovasc Surg on June 01, 2004
Management of a complicated ruptured infected pseudoaneurysm of the femoral artery in a drug addict. Case Rep Vasc Med (2012) 0.79
Endovascular treatment of bleeding external iliac artery pseudo-aneurysm following control of haemorrhage with Sengstaken tube during revision total hip arthroplasty. Ann R Coll Surg Engl (2007) 0.75
Delayed torrential haemorrhage after firearm injury. BMJ Case Rep (2014) 0.75
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes. Microbiology (1997) 2.61
Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ (2002) 2.13
Ankle Brachial Pressure Index: identifying cardiovascular risk and improving diagnostic accuracy. J R Soc Med (2007) 2.07
Comparison of POSSUM and the Portsmouth predictor equation for predicting death following vascular surgery. Br J Surg (1998) 1.95
Size and age-sex distribution of pediatric practice: a study from Pediatric Research in Office Settings. Arch Pediatr Adolesc Med (1999) 1.77
Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists. Cancer Res (1985) 1.55
Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Res (1999) 1.52
The analysis of sensitivity, specificity, positive predictive value and negative predictive value of cold provocation thermography in the objective diagnosis of the hand-arm vibration syndrome. Occup Med (Lond) (2001) 1.52
Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol (2003) 1.50
Randomized clinical trial of intraoperative autotransfusion in surgery for abdominal aortic aneurysm. Br J Surg (2004) 1.49
Outcome following saphenopopliteal surgery: a prospective observational study. Phlebology (2010) 1.43
Clinical examination of varicose veins--a validation study. Ann R Coll Surg Engl (2000) 1.42
Effects of photoactivated porphyrins at the cell surface of leukemia L1210 cells. Biochemistry (1977) 1.39
Sources of error in intra-arterial pressure measurements across a stenosis. Eur J Vasc Endovasc Surg (1998) 1.39
An audit of out of hours interventional vascular radiology. Eur J Vasc Endovasc Surg (2003) 1.38
Rapid initiation of apoptosis by photodynamic therapy. Photochem Photobiol (1996) 1.37
Simplifying the internal iliac artery aneurysm. Ann R Coll Surg Engl (2001) 1.33
Properties of deoxycytidine kinase partially purified from L1210 cells. J Biol Chem (1968) 1.32
Sites of photosensitization by derivatives of hematoporphyrin. Photochem Photobiol (1986) 1.32
Staphylococcus aureus Cap5O has UDP-ManNAc dehydrogenase activity and is essential for capsule expression. Infect Immun (2001) 1.30
Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology (1999) 1.27
Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response. Cancer Res (1968) 1.25
Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol (1997) 1.25
Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J Invest Dermatol (1998) 1.21
Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin Radiol (2008) 1.20
Mesenchymal/epithelial induction mediates olfactory pathway formation. Neuron (2000) 1.20
Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem Photobiol (1987) 1.19
Effects of camptothecin on RNA synthesis in leukemia L1210 cells. Biochim Biophys Acta (1971) 1.18
Transport and binding of hematoporphyrin derivative and related porphyrins by murine leukemia L1210 cells. Cancer Res (1981) 1.17
Modes of uptake of methotrexate by normal and leukemic human leukocytes in vitro and their relation to drug response. Cancer Res (1968) 1.16
Hematoporphyrin and HPD: photophysics, photochemistry and phototherapy. Photochem Photobiol (1984) 1.15
Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett (1986) 1.14
Staphylococcus aureus cap5P encodes a UDP-N-acetylglucosamine 2-epimerase with functional redundancy. J Bacteriol (1999) 1.13
On the characteristics of actinomycin D resistance in L5178Y cells. Cancer Res (1970) 1.13
Bronchopulmonary infection with Pseudomonas aeruginosa in patients infected with human immunodeficiency virus. Genitourin Med (1995) 1.10
Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro. Cancer Res (1969) 1.08
Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem Photobiol (1997) 1.08
Components of hematoporphyrin derivatives and their tumor-localizing capacity. Cancer Res (1982) 1.08
Side effects and photosensitization of human tissues after aminolevulinic acid. J Surg Res (1997) 1.08
Subclavian stents and stent-grafts: cause for concern? J Endovasc Surg (1999) 1.08
Exercise-induced neutrophil activation in claudicants: a physiological or pathological response to exhaustive exercise? Eur J Vasc Endovasc Surg (1998) 1.07
Strategies for the management of SVC stent migration into the right atrium. Cardiovasc Intervent Radiol (2007) 1.03
On the preparation and properties of dihematoporphyrin ether, the tumor-localizing component of HPD. Photochem Photobiol (1985) 1.03
Surgery versus thrombolysis for acute limb ischaemia: initial management. Cochrane Database Syst Rev (2002) 1.02
Tumor-localizing components of the porphyrin preparation hematoporphyrin derivative. Cancer Res (1983) 1.02
Mode of action of calcium antagonists which alter anthracycline resistance. Biochem Pharmacol (1984) 1.01
A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation. Cell Death Differ (2004) 1.00
Proposed structure of the tumor-localizing fraction of HPD (hematoporphyrin derivative). Photochem Photobiol (1986) 0.99
The endovascular management of blue finger syndrome. Eur J Vasc Endovasc Surg (1999) 0.99
Elevated plasma sialyltransferase in the cancer patient. Cancer Res (1975) 0.99
Kinin effects on chloride secretion do not require eicosanoid synthesis. Br J Pharmacol (1984) 0.99
Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice. Cancer Lett (1985) 0.98
Biological and biophysical properties of the tumor-localizing component of hematoporphyrin derivative. Cancer Res (1985) 0.98
Chemistry of hematoporphyrin-derived photosensitizers. Photochem Photobiol (1987) 0.98
Inhibition of glycoprotein synthesis in L5178Y mouse leukaemic cells by L-asparaginase in vitro. Nature (1970) 0.98
Uptake as a determinant of methotrexate response in mouse leukemias. Science (1965) 0.97
Photodynamic effects: porphyrin vs chlorin. Photochem Photobiol (1984) 0.94
Studies on the genesis of Vibrio cholerae O139: identification of probable progenitor strains. J Med Microbiol (1995) 0.94
Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia. Biochim Biophys Acta (1968) 0.93
Enhanced glycosylation induced by adriamycin. Mol Pharmacol (1979) 0.93
Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs. Cancer Treat Rep (1985) 0.93
An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. J Photochem Photobiol B (1996) 0.93
Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Photochem Photobiol (1994) 0.92
Determinants of photosensitization by mono-L-aspartyl chlorin e6. Photochem Photobiol (1989) 0.92
Internal iliac artery aneurysm--a cause of leg swelling and cellulitis. J R Soc Med (2004) 0.92
Direct detection of singlet oxygen sensitized by haematoporphyrin and related compounds. Photochem Photobiol (1986) 0.92
Studies on drug transport by normal human leukocytes. Biochem Pharmacol (1967) 0.91
Current concepts in gastrointestinal photodynamic therapy. Ann Surg (1999) 0.91
Uptake in vivo and in vitro of actinomycin D by mouse leukemias as factors in survival. Biochem Pharmacol (1968) 0.91
The aetiology of Raynaud's phenomenon. Cardiovasc Surg (1998) 0.91
Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochem Mol Biol Int (1996) 0.91
Phototherapy of cancer and atheromatous plaque with texaphyrins. J Clin Laser Med Surg (1996) 0.91
Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid. J Photochem Photobiol B (1997) 0.90
Mammographic assessment of the symptomatic nonsuspicious breast. Am J Surg (1997) 0.90
Retention of 6-mercaptopurine derivatives by intact cells as an index of drug response in human and murine leukemias. Cancer Res (1969) 0.90
L-asparaginase effects on intact murine leukemia cells and on isolated cell plasma membranes. Biochem Biophys Res Commun (1972) 0.90
Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens. Biochem Pharmacol (1986) 0.90
Studies on camptothecin-induced degradation and apparent reaggregation of DNA from L1210 cells. Biochem Biophys Res Commun (1972) 0.89
Membrane alterations associated with progressive adriamycin resistance. Biochem Pharmacol (1982) 0.89
Effects of Cremophor EL on distribution of Taxol to serum lipoproteins. Br J Cancer (1994) 0.89
Community acquired lobar pneumonia in patients with HIV infection and AIDS. Thorax (1994) 0.89
Hemodynamic effects of 5-aminolevulinic acid in humans. J Photochem Photobiol B (1998) 0.88
Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch Surg (1996) 0.88
Alterations in plasma sialyltransferase levels in patients with neoplastic disease. Cancer (1977) 0.88
Photosensitization with derivatives of chlorophyll. Photochem Photobiol (1989) 0.88
Amethopterin transport in Ehrlich ascites carcinoma and L1210 cells. Cancer Res (1967) 0.88
The alteration of plasma lipoproteins by cremophor EL. J Photochem Photobiol B (1994) 0.88
Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans. J Photochem Photobiol B (2000) 0.87
False aneurysm of the peroneal artery: an unusual complication of femoro-peroneal bypass grafting. Cardiovasc Surg (2002) 0.87
Selective inhibition of a plasma fucosyltransferase by N-ethylmaleimide. Biochem Biophys Res Commun (1977) 0.86
Chemical, biologic and biophysical studies on 'hematoporphyrin derivative'. Adv Exp Med Biol (1985) 0.86
Probing the structure and stability of the tumor-localizing derivative of hematoporphyrin by reductive cleavage with LiAlH4. Cancer Res (1987) 0.85
Prospective analysis of quality of life in patients following infrainguinal reconstruction for chronic critical ischaemia. Br J Surg (1998) 0.85
Camptothecin effects on DNA synthesis in murine leukemia cells. Biochim Biophys Acta (1972) 0.85
Porphyrin localization: a new modality for detection and therapy of tumors. Biochem Pharmacol (1984) 0.85
Radiology curriculum for undergraduate medical studies--a consensus survey. Clin Radiol (2012) 0.85
Effects of S-(trityl)-L-cysteine and its analogs on cell surface properties of leukemia L1210 cells. Biochem Pharmacol (1976) 0.84
A dihydropyridine carrier system for sustained delivery of 2',3'-dideoxynucleosides to the brain. J Med Chem (1989) 0.84